Cosmetics Quality Control & Regulatory Enforcement: Drug Administration of Vietnam Orders Nationwide Recall of Intimate Wash, Body Care, and Shampoos – Citing Microbiological Contamination and Formulation Non-Compliance

Key Development

On September 7, 2026, the Drug Administration of Vietnam (DAV) under the Ministry of Health issued official regulatory directives ordering nationwide market suspensions, recalls, and destructions targeting six cosmetic and personal hygiene products due to confirmed microbial contamination and significant deviations from approved formulation dossiers.

Product breakdown, responsible legal entities, and regulatory actions:

  • Microbiological failure in intimate hygiene products:

    • Product Name: Victory Herbal Feminine Hygiene Solution (Dung dich ve sinh phu nu Thao duoc Victory, 300ml presentation).

    • Batch Identifiers: Cosmetic Notification Receipt Number: 06/26/CBMP-NA; Batch: 010426; Manufacturing Date: June 15, 2026; Shelf-life: 36 months.

    • Manufacturing and commercial registrant: Chien Thang Pharmaceutical Co., Ltd. (Address: No. 17 Thanh Thai Street, Quang Phuc Block, Truong Vinh Ward, Nghe An Province).

    • Statutory violation: Laboratory testing confirmed non-compliance with permissible microbiological limit parameters established under the ASEAN Cosmetic Directive.

    • Regulatory mandate: The Nghe An Department of Health was instructed to supervise the complete recall and destruction of the defective batch, audit Chien Thang Pharmaceutical for broader regulatory compliance, impose statutory administrative penalties, and submit an official report to the DAV prior to October 10, 2026.

  • Unapproved formulation discrepancies:

    • Contract manufacturer: Bao Loi Cosmetics Co., Ltd. (Tan Hong Industrial Cluster, Duong An Commune, Hai Phong City).

    • Statutory violation: Commercial formulations distributed across retail channels diverged from the registered formulation files previously approved by health authorities.

    • Affected commercial lines:

      1. CURIA Shampoo (Notification Receipt: 200/25/CBMPHD), marketed directly by Bao Loi Cosmetics Co., Ltd.

      2. A suite of four products marketed under the VLIACARE brand franchise (encompassing body wash, shampoo, hair conditioner, and liquid hand wash), commercially distributed by Nhat Linh Glow Beauty Co., Ltd. (Address: No. 28, Alley 624 Minh Khai, Vinh Tuy Ward, Hanoi).

    • Compliance deadlines: Bao Loi Cosmetics and Nhat Linh Glow Beauty must notify distributors, collect returned stock, and complete product destruction, submitting verified destruction reports to the DAV before September 26, 2026. Concurrently, the municipal Departments of Health of Hanoi and Hai Phong must audit corporate records and file final enforcement reports by October 10, 2026.

Why It Matters

  • Preventing reproductive health infections from contaminated washes: Feminine intimate washes contact mucosal tissue where microbial balance is critical. Formulations harboring bacteria or fungi exceeding safety thresholds can alter the vaginal microbiome, provoking vulvovaginitis, cervical irritation, and ascending reproductive tract infections.

  • Enforcing formulation integrity in post-market surveillance: Deviating from approved formulation files undermines regulatory oversight. Unapproved ingredient substitutions—often made to reduce input costs or alter stabilization—can expose consumers to unlisted irritants, contact allergens, or banned preservative compounds lacking safety assessments.

  • Strict regulatory timelines drive accountability: Establishing concrete compliance deadlines (recalls finalized by September 26, 2026; provincial inspection reports submitted by October 10, 2026) reinforces regulatory enforcement and prevents administrative delays in taking non-compliant products off shelves.

Healthcare Insight Analysis

From the perspective of Healthcare Insight, the regulatory enforcement on September 7, 2026, illustrates Inter-Provincial Market Surveillance and Stricter Oversight of OEM/ODM Cosmetic Supply Chains.

The regulatory actions highlight three foundational compliance themes:

  1. Coordinated regulatory enforcement across multiple jurisdictions: Because production took place at an industrial cluster in Hai Phong while commercial brand management was located in Hanoi, the DAV coordinated concurrent audits between the Hanoi and Hai Phong Departments of Health to reconcile manufacturing batch records with commercial distribution logs.

  2. Industrial hygiene challenges in localized manufacturing facilities: The microbial limit failure at Chien Thang Pharmaceutical in Nghe An highlights ongoing quality assurance vulnerabilities in regional plants, specifically regarding process water purification, air handling system validation, and clean-in-place (CIP) sanitation protocols.

  3. Legal accountability for commercial brand holders (Private Labels): The enforcement actions directed at Nhat Linh Glow Beauty demonstrate that brand marketers cannot transfer regulatory responsibility to third-party contract manufacturers. Corporate entities that notify products remain legally liable for verifying that commercial products match approved dossiers.

Market Implications

  1. Retail pharmacy and digital platform product screenings: Community pharmacies, drugstore retail chains, and e-commerce platforms (Shopee, TikTok Shop, Lazada) must quarantine and return affected inventory to avoid financial penalties during provincial health inspections.

  2. Comprehensive regulatory scrutiny across therapeutic categories: The simultaneous national recall of an imported batch of Colchicina Seid (Colchicine 1mg) tablets indicated broader regulatory sampling across both specialized ethical pharmaceuticals and daily personal hygiene commodities.

  3. Market consolidation favoring accredited cGMP facilities: Increasing regulatory scrutiny makes contract outsourcing more selective, driving independent beauty and wellness brands toward contract manufacturing facilities holding certified cGMP-ASEAN or ISO 22716 credentials with validated in-house analytical capabilities.

Regulatory Enforcement Matrix: DAV Cosmetic Suspensions and Recalls (September 7, 2026)

Commercial Product Registration & Batch Metadata Manufacturing / Commercial Entities Regulatory Violation & Mandated Timeline
Victory Herbal Feminine Wash (300ml) 06/26/CBMP-NA; Batch: 010426; Mfg: 15/06/2026 Chien Thang Pharmaceutical Co., Ltd. (Nghe An) Failed microbiological limit thresholds; Department audit report due Oct 10, 2026
CURIA Shampoo 200/25/CBMPHD Bao Loi Cosmetics Co., Ltd. (Hai Phong) Formulation differed from registered dossier; Recall report due Sept 26, 2026
VLIACARE Body Wash Approved notification files Mfg: Bao Loi Cosmetics / Dist: Nhat Linh Glow Beauty Unapproved formula deviation; Inter-provincial inspection report due Oct 10, 2026
VLIACARE Shampoo Approved notification files Mfg: Bao Loi Cosmetics / Dist: Nhat Linh Glow Beauty Unapproved formula deviation; Cease commercial sale and distribution immediately
VLIACARE Conditioner Approved notification files Mfg: Bao Loi Cosmetics / Dist: Nhat Linh Glow Beauty Unapproved formula deviation; Mandatory quarantine and product return to supplier
VLIACARE Hand Wash Approved notification files Mfg: Bao Loi Cosmetics / Dist: Nhat Linh Glow Beauty Unapproved formula deviation; Complete physical product batch destruction required

Source: https://suckhoedoisong.vn/bo-y-te-thu-hoi-toan-quoc-loat-dung-dich-ve-sinh-sua-tam-dau-goi-169260907215701401.htm

0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments